HSP90B2P and cancer: With similar fashion in other cancers, HSP (0–100 μM, 24–48 h) triggered apoptosis on human pancreatic cell line through attenuating Bcl-xL but increasing the expression of Bax and BAD and inhibiting cell proliferation via reducing the expression of NF-κβ [74].